相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
Chetasi Talati et al.
HAEMATOLOGICA (2020)
Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program
Scott R. Solomon et al.
BONE MARROW TRANSPLANTATION (2020)
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
Albin Osterroos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Mikkael A. Sekeres et al.
BLOOD ADVANCES (2020)
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
Holger J. Schunemann et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Intensity of chemotherapy for the initial management of newly diagnosed acute myeloid leukemia in older patients
Joel M. Michalski et al.
FUTURE ONCOLOGY (2019)
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Luca Maurillo et al.
ANNALS OF HEMATOLOGY (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
Supriya G. Mohile et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience
Pankit Vachhani et al.
LEUKEMIA RESEARCH (2018)
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG
Gianni B. Scappaticci et al.
ANNALS OF HEMATOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience
Mael Heiblig et al.
LEUKEMIA & LYMPHOMA (2017)
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Antonio M. Almeida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
Pierre-Yves Dumas et al.
ONCOTARGET (2017)
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens
John F. Seymour et al.
BMC CANCER (2017)
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy
Sang-Bo Oh et al.
ANNALS OF HEMATOLOGY (2017)
Characteristics and Outcomes of Older Patients With Secondary Acute Myeloid Leukemia According to Treatment Approach
Prajwal Chaitanya Boddu et al.
CANCER (2017)
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients
Koichi Takahashi et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy
Yi Chen et al.
MEDICINE (2016)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Acute myeloid leukemia: a comprehensive review and 2016 update
I. De Kouchkovsky et al.
BLOOD CANCER JOURNAL (2016)
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Herve Dombret et al.
BLOOD (2015)
Health Care Utilization and End-of-Life Care for Older Patients With Acute Myeloid Leukemia
Areej R. El-Jawahri et al.
CANCER (2015)
Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
Jihane Fattoum et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Economic analysis of blood product transfusions according to the treatment of acute myeloid leukemia in the elderly
G. Cannas et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2015)
Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: An analysis from a regional healthcare network
Pierre Bories et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
Sylvain Thepot et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis
Hyeon Gyu Yi et al.
BLOOD RESEARCH (2014)
GRADE guidelines: 12. Preparing Summary of Findings tables-binary outcomes
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients
Lieke H. van der Helm et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2012)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2012)
Acute myeloid leukemia in the real world: why population-based registries are needed
Gunnar Juliusson et al.
BLOOD (2012)
Incidence, survival and prevalence of myeloid malignancies in Europe
O. Visser et al.
EUROPEAN JOURNAL OF CANCER (2012)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical Challenge
Felicetto Ferrara
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*
Valeria Santini et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Pierre Fenaux et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Outcomes and Quality of Care in Acute Myeloid Leukemia Over 40 Years
Shabbir M. H. Alibhai et al.
CANCER (2009)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older
A Bashey et al.
LEUKEMIA RESEARCH (2006)
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation
G Jackson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
